Lomustine

Details of the Drug

Generic Name:: Lomustine
Pronunciation:: loh-MUS-teen
Drug Type:: DNA-damaging agent
How the Drug is Given:: By mouth
Names:: CeeNU®; CCNU; Lomustine

Indications and Usage

Lomustine is FDA approved as a secondary therapy in combination with other drugs to treat people with Hodgkin lymphoma who relapse while being treated with primary therapy or who fail to respond to primary therapy.

Side effects needing medical attention

Fever, chills or sore throat; unusual bleeding or bruising; infection; confusion; slurred speech; sores in mouth and on lips; swelling of feet or lower legs; unusual decrease in urination; unusual tiredness or weakness; yellowing of eyes and skin; cough or shortness of breath.

For information on how to manage the costs of drug therapy, please see Financial Support, or to speak with an Information Specialist, call (800) 955-4572.